Table 1.
Demographic and Clinical Characteristics
| Study Subjects (N = 36) |
|
|---|---|
| Agea | 5.09/4.62 |
| Range | (1.75 – 10.58) |
| Age under 3 years – no. (%) | 7(19) |
| Female sex – no. (%) | 19 (53) |
| Race – no. (%) | |
| Black/African American | 1 (3) |
| White/Caucasian | 30 (83) |
| Asian | 2 (6) |
| Multiple races | 3 (8) |
| Ethnicity – no. (%) | |
| Non-Hispanic | 31(86) |
| Hispanic | 5 (14) |
| Diagnosis – no. (%) | |
| NF1 with OPG | 24(67) |
| Sporadic OPG | 12(33) |
| Mental Health/Learning Disability– no. (%) | |
| NF1 with OPG | 9(25) |
| Sporadic OPG– no. (%) | 5(14) |
| Treatment of OPG– no. (%) | |
| Never Treated | 16 (44) |
| Treated | 20 (56) |
| Past Treatmentb | 11 |
| Currently undergoing chemotherapy | 9 |
a
In years mean/median and (range);
b
Includes chemotherapy or radiation (N=2)